Top Stocks Surge After Strong Q2 Results: Alnylam, Carvana, Air Products Lead

1. Alnylam Pharmaceuticals (Nasdaq: ALNY)
Alnylam Pharmaceuticals surged by 13.12%. Alnylam Pharmaceuticals reported its second quarter fiscal 2024 results on August 1. Cantor Fitzgerald, Morgan Stanley, and Canaccord Genuity all maintained their ratings on Alnylam Pharmaceuticals, with price targets set at $220.00, $255.00, and $357.00 respectively. Yvonne Greenstreet sold 7,093 shares on July 11.

2. Carvana (NYSE: CVNA)
Carvana surged by 10.05%. Carvana reported second-quarter fiscal 2024 results with revenue of $34 billion, net income of $48 million, and EPS of $0.14. Morgan Stanley maintains an Underweight rating, while Wells Fargo upgraded to Overweight at $175, and Needham maintains Buy at $200.

3. Air Products And Chemicals (NYSE: APD)
Air Products And Chemicals surged by 8.87%. Air Products and Chemicals will report its Third Quarter financial results for fiscal 2024 on August 1. Deutsche Bank downgraded the company to Hold and lowered the price target to $280. Citigroup maintains a Buy rating, raising the target to $305.

4. Iron Mountain Incorporated (NYSE: IRM)
Iron Mountain Incorporated surged by 6.83%. Iron Mountain reported its Second Quarter fiscal 2024 results on August 1, 2024. Wells Fargo maintains an Overweight rating with a price target of $110.00. Stifel maintains a Buy rating with a price target of $103.00. Recent insider transactions were disclosed in July.

5. Aflac Incorporated (NYSE: AFL)
Aflac Incorporated surged by 6.45%. Aflac's second quarter fiscal 2024 results showed net income attributable to common shareholders. B of A Securities maintains a Buy rating on Aflac, increasing the price target to $108.00. Citigroup and JP Morgan maintain neutral ratings with targets of $93.00 and $83.00, respectively.